Overview

Combined Use of Oxytocin and Misoprostol in the Prevention of Post Partum Haemorrhage

Status:
Terminated
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
To demonstrate that the combined used of oxytocin and misoprostol prevent from post partum haemorrhage better than oxytocin alone, following vaginal birth at 36 to 42 weeks.
Phase:
Phase 4
Details
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Treatments:
Misoprostol
Oxytocin